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RESEARCH ARTICLE
Tropomodulin 1 directly controls thin filament length in both
wild-type and tropomodulin 4-deficient skeletal muscle
David S. Gokhin1,*, Julien Ochala2, Andrea A. Domenighetti3,4 and Velia M. Fowler1,*
ABSTRACT
The sarcomeric tropomodulin (Tmod) isoforms Tmod1 and Tmod4
cap thin filament pointed ends and functionally interact with the
leiomodin (Lmod) isoforms Lmod2 and Lmod3 to control myofibril
organization, thin filament lengths, and actomyosin crossbridge
formation in skeletal muscle fibers. Here, we show that Tmod4 is
more abundant than Tmod1 at both the transcript and protein level in
a variety of muscle types, but the relative abundances of sarcomeric
Tmods are muscle specific. We then generate Tmod4−/− mice, which
exhibit normal thin filament lengths, myofibril organization, and
skeletal muscle contractile function owing to compensatory
upregulation of Tmod1, together with an Lmod isoform switch
wherein Lmod3 is downregulated and Lmod2 is upregulated.
However, RNAi depletion of Tmod1 from either wild-type or
Tmod4−/− muscle fibers leads to thin filament elongation by ∼15%.
Thus, Tmod1 per se, rather than total sarcomeric Tmod levels,
controls thin filament lengths in mouse skeletal muscle, whereas
Tmod4 appears to be dispensable for thin filament length regulation.
These findings identify Tmod1 as the key direct regulator of thin
filament length in skeletal muscle, in both adult muscle homeostasis
and in developmentally compensated contexts.
KEY WORDS: Actin filament, Pointed-end capping, Leiomodin,
Myofibril, Sarcomere
INTRODUCTION
The semicrystalline arrays of interdigitating, uniform-length actin
(thin) and myosin (thick) filaments found in the contracting
sarcomeres of skeletal muscle fibers represent a striking example
of long-range cytoskeletal organization and precise organelle size
control. Whereas thick filament lengths are essentially constant in
all skeletal muscles and species examined (∼1.65 µm), thin filament
lengths vary substantially across muscles and vertebrate species
(0.95-1.40 µm) (Castillo et al., 2009; Gokhin et al., 2012, 2010;
Granzier et al., 1991; Ringkob et al., 2004). Thin filament lengths
are remarkably plastic during normal postnatal skeletal muscle
development and aging (Gokhin et al., 2014a) but can become mis-
specified in some congenital myopathies. For example, thin
filaments are abnormally short owing to aberrant F-actin assembly
and/or destabilization in some nemaline myopathies (Ochala et al.,
2012; Ottenheijm et al., 2010, 2009; Yuen et al., 2014), whereas
thin filaments elongate as a result of pointed-end uncapping and
actin subunit addition in mouse models of Duchenne muscular
dystrophy (Gokhin et al., 2014b). Mis-specification of thin filament
lengths frequently occurs with alterations in thin filament activation
and/or actomyosin crossbridge formation (Chandra et al., 2009;
Ochala et al., 2012; Ottenheijm et al., 2013, 2010).
Crucial players in the simultaneous regulation of thin filament
lengths, thin filament activation, and actomyosin crossbridge
formation are the tropomodulin (Tmod) family of tropomyosin
(TM)-binding and actin filament pointed-end capping proteins.
Vertebrate skeletal muscles contain two sarcomeric Tmod isoforms:
Tmod1, expressed in diverse, terminally differentiated cells,
including striated muscle, but also erythrocytes, neurons and
ocular lens fiber cells; and Tmod4, which is exclusive to skeletal
muscle fibers (Almenar-Queralt et al., 1999; Conley et al., 2001;
Gokhin and Fowler, 2011b; Yamashiro et al., 2012). Two
sarcomeric Tmod molecules cap each thin filament pointed end
and bind to the N-termini of the terminal α/βTM molecules on the
thin filaments (Almenar-Queralt et al., 1999; Fowler et al., 1993;
Gokhin and Fowler, 2011b; Gokhin et al., 2012, 2010, 2014b).
Tmod4 is approximately tenfold more abundant than Tmod1 in a
mixture of isolated tibialis anterior (TA) and extensor digitorum
longus (EDL) myofibrils (Gokhin et al., 2014b), indicating that
Tmod4 is probably the predominant pointed-end cap in skeletal
muscle thin filaments, at least in fast muscle. In addition, an
extrasarcomeric Tmod isoform, Tmod3, caps the pointed ends of
cytoplasmic γ-actin filaments in a sarcoplasmic reticulum (SR)-
associated cytoskeletal network (Gokhin and Fowler, 2011a).
Skeletal muscle also contains two leiomodin (Lmod) isoforms,
Lmod2 and Lmod3, which are larger Tmod family members that
nucleate F-actin assembly and can antagonize the capping activity
of Tmods (Chereau et al., 2008; Conley et al., 2001; Pappas et al.,
2015; Tsukada et al., 2010; Yuen et al., 2014).
Tmod perturbation studies in cultured cardiomyocytes and
Drosophila indirect flight muscle have demonstrated that
sarcomeric Tmods control thin filament lengths by dynamically
regulating actin subunit association/dissociation from pointed ends
(Bliss et al., 2014; Gregorio et al., 1995; Littlefield et al., 2001;
Mardahl-Dumesnil and Fowler, 2001; Sussman et al., 1998) and by
stabilizing pointed ends via their interactions with terminal α/βTMs
(Mudry et al., 2003). A role for sarcomeric Tmods in regulating thin
filament lengths has also been implicated in mammalian skeletal
muscle, in which calpain-mediated proteolysis of sarcomeric Tmods
in dystrophic muscle is associated with thin filament elongation
(Gokhin et al., 2014b), although potential indirect effects due to
non-Tmod-related mechanisms have not been ruled out. However,
recent analyses of mouse knockouts have uncovered more complex
functions of sarcomeric Tmods in mammalian skeletal muscle
contractility, as well as unexpected compensatory mechanisms. In
Tmod1−/− muscle, Tmod3 compensates for the absence of Tmod1
by translocating from its SR compartment to the thin filament
pointed ends to preserve normal skeletal muscle development,Received 29 July 2015; Accepted 5 November 2015
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myofibril assembly and thin filament lengths (Gokhin and Fowler,
2011a; Gokhin et al., 2010). The switch from pointed-end capping
by Tmod1 and Tmod4 in wild-type muscle to pointed-end capping
by Tmod3 and Tmod4 in Tmod1−/− muscle impairs initial α/βTM
movement during thin filament activation, inhibiting the formation
of productive actomyosin crossbridges and depressing isometric
force production (Ochala et al., 2014).
Although analyses of dystrophic and Tmod1−/− skeletal muscles
have provided substantial insights into how sarcomeric Tmods
regulate thin filament lengths and muscle physiology, direct
evidence for Tmod-mediated regulation of skeletal muscle thin
filament lengths has not been found. Additionally, the
approximately tenfold greater abundance of Tmod4 than Tmod1
in TA and EDL myofibrils (Gokhin et al., 2014b) led us to
hypothesize that the properties of Tmod4 at pointed ends are distinct
from those of Tmod1. Here, we report that Tmod4 is more abundant
than Tmod1 at both the transcript and protein level in both fast- and
slow-switch muscles, but molar ratios of sarcomeric Tmods are
muscle specific. We then generated a novel Tmod4−/− mouse and
unexpectedly discovered that Tmod4−/−muscles exhibit normal thin
filament lengths and contractile function owing to compensatory
upregulation of Tmod1, with accompanying downregulation of
Lmod3 and upregulation of Lmod2. RNAi depletion of Tmod1
from either wild-type or Tmod4−/− muscles leads to actin subunit
addition onto pointed ends and identical extents of thin filament
elongation, indicating that Tmod1 and not Tmod4 is required for
thin filament length regulation in mouse skeletal muscles. These
findings demonstrate that pointed-end capping by sarcomeric
Tmods directly controls thin filament lengths in both adult muscle
homeostasis and in developmentally compensated contexts.
RESULTS
Gene expression and protein abundance of sarcomeric
Tmods
To determine whether the relative abundances of Tmod4 and
Tmod1 are fixed or variable across muscle types, we performed
quantitative western blotting of diverse skeletal muscles (TA, soleus
and diaphragm) lysates and determined the molar ratio of
sarcomeric Tmods in each muscle. Tmod4 was more abundant
than Tmod1 in all muscles examined, but Tmod4 ranged from
approximately nine- to tenfold more abundant than Tmod1 in TA,
approximately fourfold more abundant in soleus, and approximately
threefold more abundant in diaphragm (Table 1), indicating that
sarcomeric Tmod isoform distributions are muscle type dependent.
In all muscles, approximately two sarcomeric Tmods were
associated with each thin filament pointed end (Table 1), as
observed previously (Gokhin et al., 2014b). Note that the higher
Tmod1 levels observed in soleus and diaphragm muscles (Table 1)
might be due to the heavier vascularization of these muscles and the
presence of Tmod1-containing erythrocytes (Moyer et al., 2010).
However, this is unlikely, as we do not observe noteworthy
differences in Tmod1 abundances in isolated myofibrils versus
whole-muscle lysates (compare Table 1 and data published by
Gokhin et al., 2014b). Alternatively, slow muscles such as the
soleus and diaphragm might contain more extrasarcomeric Tmod1
than do fast muscles, possibly associated with the SR or T-tubules
(Gokhin and Fowler, 2011a), leading to higher total Tmod1 levels.
Next, to determine whether the greater abundance of Tmod4
compared with Tmod1 in various skeletal muscles could be
explained by differences in gene expression, we analyzed the
expression of Tmod genes in diverse striated muscles [TA, soleus,
diaphragm and cardiac left ventricle (LV)] using RNA-seq. Tmod4
mRNA was more abundant than Tmod1 mRNA in TA, soleus and
diaphragm (Fig. 1A), consistent with the higher levels of Tmod4
protein in these muscles (Table 1); this observation was confirmed
by qRT-PCR (Fig. 1B). By contrast, Tmod1 mRNA was more
abundant than Tmod4mRNA in LV (Fig. 1A), as expected (Gokhin
and Fowler, 2011b). Therefore, muscle-specific molar ratios of
Tmod4:Tmod1 proteins correlate with mRNA levels.
To complete our survey of Tmod family gene expression, we
examined the expression of nonsarcomeric Tmod genes, as well as
Lmod genes. Expression of Tmod3 mRNA was low but above
background in all striated muscles examined (Fig. 1A), consistent
with Tmod3’s SR association with γcyto-actin (Gokhin and Fowler,
2011a), an actin isoform that is ∼1/4000th as abundant as the αsk-
actin that comprises the thin filaments (Hanft et al., 2006). Lmod2




















Expt. 1 0.44±0.09 4.19±0.37 980±48 9.6 210 1.9
Expt. 2 0.53±0.09 4.77±0.30 1044±112 9.0 197 2.0
Expt. 3 0.42±0.17 4.25±0.34 1017±98 10.1 218 1.8
Soleus
Expt. 1 0.89±0.28 3.46±0.45 962±69 3.9 221 1.9
Expt. 2 0.74±0.16 3.34±0.52 1040±126 4.5 198 2.2
Expt. 3 1.05±0.13 4.02±0.29 936±46 4.0 238 1.8
Diaphragm
Expt. 1 1.33±0.35 4.21±0.33 1035±105 3.2 214 2.0
Expt. 2 1.48±0.39 4.47±0.54 1127±132 3.1 189 2.3
Expt. 3 1.50±0.42 4.39±0.51 1070±163 2.9 191 2.2
*Amounts of sarcomeric Tmods were determined by quantitative western blotting and densitometry of skeletal muscle myofibrils (1-8 μl gel sample)
electrophoresed alongside purified recombinant protein standards (0.25-4 ng) on the same gel. Tmod1 or Tmod4 protein standards were mixed with Tmod1−/− or
Tmod4−/− TA muscle lysates, respectively, to equalize the effects of endogenous non-Tmod proteins on the western transfer efficiencies of endogenous versus
recombinant purified Tmods. Standard deviations reflect three to four different myofibril volumes from different lanes on the same blot.
‡Amounts of actin were determined by densitometry of Coomassie Blue-stained gels containing skeletal muscle myofibrils (1-8 μl gel sample) electrophoresed
alongside rabbit skeletal muscle actin standards (0.25-4 μg) on the same gel. Standard deviations reflect three to four different myofibril volumes from different
lanes on the same gel.
§Numbers of Tmods/thin filament were calculated based on 13 actin subunits per 37 nm of thin filament (Fowler et al., 1993).
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and Lmod3 mRNAs were detected in all striated muscles, in
agreement with previous studies (Cenik et al., 2015; Chereau et al.,
2008; Conley et al., 2001; Nworu et al., 2015; Tian et al., 2015;
Yuen et al., 2014), but an unexpected muscle type dependence was
observed, with Lmod2mRNA predominating in slow-twitch soleus,
diaphragm, and left ventricular muscles and Lmod3 mRNA more
highly expressed than Lmod2 mRNA in fast-twitch TA muscle
(Fig. 1C). Tmod2 and Lmod1 mRNAs were not detected in striated
muscles (Fig. 1A,C), consistent with Tmod2 expression being
restricted to neuronal tissues (Cox et al., 2003; Watakabe et al.,
1996) and Lmod1 expression being restricted to smooth muscle
(Conley et al., 2001; Nanda and Miano, 2012).
Deletion of Tmod4 induces compensatory upregulation of
Tmod1 to maintain normal myofibril organization, thin
filament lengths and muscle function
Because Tmod4, and not Tmod1, is the predominant sarcomeric
Tmod isoform in mouse skeletal muscles (Table 1), we explored the
effects of Tmod4 deficiency in mice by generating Tmod4−/− mice,
which lack Tmod4 protein in skeletal muscle (Fig. 2A-C).
Surprisingly, Tmod4−/− mice were born in Mendelian ratios and
were viable and fertile, with no overt myopathy, identical to
Tmod4+/+ and Tmod4+/− mice. TA, EDL and soleus muscles from
Tmod4−/− mice exhibited no abnormalities in terms of centralized
nuclei (Fig. 2D,E), fiber cross-sectional area (Fig. 2F), MHC
distribution (Fig. 2G), myofibrillar ultrastructure (Fig. 2H) and
physiological parameters (Fig. 2I-L). Immunostaining for α-actinin
and phalloidin staining for F-actin confirmed normal organization
of striated arrays of Z-lines and thin filaments in Tmod4−/− muscles
(Fig. 3A). Thus, Tmod4 appears to be dispensable for myofibril
organization and skeletal muscle function in mice.
To test whether Tmod1 and/or Tmod3 could compensate for the
absence of Tmod4 in Tmod4−/− mice, we immunostained
longitudinal cryosections of Tmod4+/+ and Tmod4−/− muscles for
Tmod1 and Tmod3. In both Tmod4+/+ and Tmod4−/− muscles,
Tmod1 exhibited its familiar striated staining pattern of periodic
doublets, corresponding to the pointed ends of phalloidin-stained
thin filaments, but the fluorescence intensity of Tmod1 was
qualitatively brighter in Tmod4−/− muscles, suggesting higher
levels of Tmod1 (Fig. 3B; Fig. S1A). This was confirmed by
western blotting, which showed approximately six- to eightfold
increases in Tmod1 protein levels in Tmod4−/−muscles (Fig. 3D,E),
which was driven by approximately five- to sixfold increases in
Tmod1 gene expression (Fig. 3F). Thus, the increased Tmod1
repopulated most of the pointed ends rendered vacant by the
absence of Tmod4 (Table 1; Fig. 3H). Similar compensatory
increases in Tmod1 protein levels were observed in leg and flank
muscles from newborn (P0) Tmod4−/− mice (Fig. S2), indicating
that compensatory elevation of Tmod1 levels occurs sometime
during embryonic skeletal muscle development of Tmod4−/− mice
and does not require postnatal muscle contractility and use. Unlike
Tmod1, Tmod3 localized predominantly to Z-line-flanking puncta
and to a lesser extent to M-line puncta in both Tmod4+/+ and
Tmod4−/− muscles (Fig. 3C; Fig. S1B), indicative of the SR
localization of Tmod3 (Gokhin and Fowler, 2011a), but protein
levels of Tmod3 were unchanged in Tmod4−/−muscles (Fig. 3D,E).
Therefore, Tmod1 compensates for the absence of Tmod4 via an
increase in protein levels. This compensation mechanism differs
from that of Tmod1−/−muscle, wherein Tmod3 compensates for the
absence of Tmod1 via translocation from the SR and no change in
protein levels (Gokhin and Fowler, 2011a; Gokhin et al., 2010).
However, this compensationmechanism resembles that of Tmod2−/−
brain, wherein Tmod1 protein levels are increased approximately
eightfold to compensate for the absence of Tmod2 in neurons (Cox
et al., 2003).
Next, we investigated whether the switch from Tmod1/Tmod4
pointed-end capping in Tmod4+/+ muscle to exclusively Tmod1
pointed-end capping in Tmod4−/− muscle might alter thin filament
lengths. Hence, we performed distributed deconvolution (DDecon)
analysis of line-scans from fluorescence images to measure thin
filament lengths based on distances of sarcomeric Tmods from the
Z-line as well as by breadths of the F-actin striations (Gokhin and
Fowler, 2013; Littlefield and Fowler, 2002). In both Tmod4+/+ and
Tmod4−/− TA muscles, thin filament lengths were ∼1.07 µm
determined by Tmod distance and ∼0.99 µm determined by F-
actin breadth (Fig. 3G), in agreement with previous studies (Gokhin
et al., 2010, 2014b). In both Tmod4+/+ and Tmod4−/− soleus
muscles, thin filament lengths were ∼1.18 µm determined by Tmod
distance and ∼1.10 µm determined by F-actin breadth (Fig. 3G).
Therefore, compensatory upregulation of Tmod1 preserves normal
thin filament lengths in Tmod4−/− muscle (Fig. 3H).
In skeletal muscle, thin filament lengths are stabilized by nebulin,
a giant protein that co-extends with thin filaments, protects thin
filaments from depolymerization and shortening, and attenuates
Fig. 1. Gene expression of Tmod family members in striated muscles. (A) Expression of Tmod1-4 mRNAs in TA, soleus, diaphragm and LV muscle
determined by RNA-seq. (B) Expression of Tmod1 and Tmod4mRNAs in TA and soleusmuscles determined by qRT-PCR. Error bars reflect mean±s.e.m. of n=3
replicates. *P<0.05. (C) Expression of Lmod1-3 mRNAs in TA, soleus, diaphragm and LV muscle determined by RNA-seq. For RNA-seq analyses, three
individual muscles of each type were pooled, and RNA-seq analysis was performed on the pooled sample; hence, no error bars are shown.
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actin and Tmod dynamics at the pointed end (Bang et al., 2006;
Pappas et al., 2011, 2010). Nebulin extends from its C-terminus
(neb-C) anchored in the Z-line to its N-terminal M1M2M3 domain
(neb-N) located at a constant distance from the Z-line (∼0.95 µm),
slightly proximal to the pointed ends where sarcomeric Tmods are
located (Gokhin and Fowler, 2013). Because nebulin and
sarcomeric Tmods are thought to collaboratively regulate thin
filament lengths, we investigated whether deletion of Tmod4 might
impact the assembly or localization of nebulin. To test this, we
immunostained longitudinal cryosections of Tmod4+/+ and
Tmod4−/− muscles for neb-N and neb-C. In both Tmod4+/+ and
Tmod4−/− muscles, neb-N localized to striations slightly proximal
to the thin filament pointed ends (Fig. 4A), as expected (Gokhin and
Fowler, 2013), whereas neb-C precisely colocalized with α-actinin
in the Z-line (Fig. 4B), also as expected (Pappas et al., 2008, 2010).
The neb-N striations in both TA and soleus muscles from Tmod4+/+
and Tmod4−/− mice were ∼0.95 μm from the Z-line, as confirmed
by DDecon analysis (Fig. 4D). Therefore, deletion of Tmod4 does
not impact nebulin localization.
Deletion of Tmod4 alters the expression of striated muscle
Lmod isoforms
Tmod4 has been proposed to interact functionally with the actin
nucleator Lmod3 near the thin filament pointed ends, based on a
dramatic decrease in Tmod4 protein levels in Lmod3-deficient
nemaline myopathy patients (Yuen et al., 2014) and the ability of
Tmod4 and Lmod3 to substitute for one another during skeletal
myofibril assembly in Xenopus (Nworu et al., 2015). To evaluate
this functional interaction, we examined whether deletion of Tmod4
might impact the localization or levels of Lmod3. In both Tmod4+/+
Fig. 2. Deletion of Tmod4 does not produce an overt myopathic phenotype. (A) Tmod4 gene targeting strategy generated by KOMP, depicting lacZ/neo
insertion into intron 2 of Tmod4. (B) Automated qPCR analysis of genomic DNA from mouse tail-snip biopsies derived from Tmod4+/− intercrosses. *P<0.001
versus other groups. (C) Western blots of homogenates of TA muscles from 2-month-old Tmod4+/+ and Tmod4−/− mice probed using an anti-Tmod4 antibody.
Gapdh was used as a loading control. (D) H&E-stained cross-sections of soleus muscles from 2-month-old Tmod4+/+ and Tmod4−/− mice. Scale bar: 300 µm.
(E,F) Histological evaluation of centralized nuclei (E) and fiber cross-sectional area (F) in TA, EDL and soleus muscles from 2-month-old Tmod4+/+ and
Tmod4−/− mice. Error bars reflect mean±s.e.m. of n=4 muscles/genotype. (G) Evaluation of MHC isoform distributions in TA, EDL and soleus muscles from
2-month-old Tmod4+/+ and Tmod4−/− mice using 8% SDS-PAGE followed by silver staining and densitometric quantification. Error bars reflect mean±s.e.m. of
n=4 muscles/genotype. (H) Representative TEM micrographs of longitudinal sections of TA and EDL muscles from 2-month-old Tmod4+/+ and Tmod4−/− mice.
Scale bars: 1 µm. (I-L) Physiological evaluation of skinned, Ca2+-activated muscle fibers from TA muscles from 2-month-old Tmod4+/+ and Tmod4−/− mice.
Shown are specific force production (I), crossbridge cycling kinetics as determined by the rate constant of force redevelopment after unloaded sarcomere
shortening (ktr; J), thin filament Ca
2+ sensitivity (pCa50; K), and cooperativity of thin filament activation [Hill coefficient (nH); L]. Error bars reflect mean±s.e.m. of
n=8 fibers/genotype.
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and Tmod4−/− muscles, Lmod3 localized to striations at or near the
thin filament pointed ends (Fig. 4C), as expected (Nworu et al.,
2015; Yuen et al., 2014). The Lmod3 striations were∼0.95 µm from
the Z-line (Fig. 4D), coincident with neb-N and not the thin filament
pointed end where Tmods are located (compare with Fig. 3G). We
were also unable to detect Tmod-Lmod associations by co-
immunoprecipitation (Fig. S3).
Surprisingly, western blotting of Tmod4−/− muscle lysates
revealed a ∼60% decrease in Lmod3 protein levels, with a
corresponding increase in Lmod2 (Fig. 4E,F). These changes in
Lmod isoform levels are due to corresponding changes in Lmod3
and Lmod2 mRNA levels (Fig. 4G). Therefore, the switch from
Tmod1/Tmod4 pointed-end capping in Tmod4+/+ muscle to solely
Tmod1 pointed-end capping in Tmod4−/− muscle shifts Lmod
isoform abundance away from Lmod3 and towards Lmod2.
However, as Tmods neither colocalize nor co-immunoprecipitate
with Lmods, preferential Tmod4/Lmod3 and Tmod1/Lmod2 co-
expression is unlikely to be regulated at the level of a protein
Fig. 3. Deletion of Tmod4 induces compensatory upregulation of Tmod1 to preservemyofibril organization and thin filament lengths. (A-C) Longitudinal
cryosections of TA muscles from 2-month-old Tmod4+/+ and Tmod4−/− mice were immunostained for Tmod4 (A), Tmod1 (B) or Tmod3 (C), immunostained for
α-actinin, and phalloidin-stained for F-actin. M, M-line; P, thin filament pointed ends; Z, Z-line. Scale bars: 1 µm. (D)Western blots of homogenates of TA, EDL and
soleus muscles from 2-month-old Tmod4+/+ and Tmod4−/− mice were probed using antibodies against Tmod4, Tmod1, Tmod3 and actin. Gapdh was used as a
loading control. (E) Quantification of western blots. Error bars reflect mean±s.e.m. of n=4 lanes/genotype within a single blot. *P<0.05. (F) Expression of Tmod1
mRNA in TA and soleusmuscles from Tmod4+/+ and Tmod4−/−mice determined by qRT-PCR. Error bars reflect mean±s.e.m. of n=3 replicates. *P<0.05. (G) Thin
filament lengths in TA and soleus muscles from 2-month-old Tmod4+/+ and Tmod4−/− mice determined using DDecon analysis of fluorescence images.
Parameters correspond to the breadth of phalloidin staining and the distances of Tmod and nebulin M1M2M3 from the Z-line. In Tmod4+/+muscle, Tmod lengths
were determined from both Tmod1 and Tmod4 immunostaining. In Tmod4−/− muscle, Tmod lengths were determined from only Tmod1 immunostaining. Error
bars reflect mean±s.d. of n=50 myofibrils/genotype randomly selected from n=4 muscles/genotype. (H) Possible model of sarcomeric Tmod isoform association
with thin filament pointed ends in sarcomeres from Tmod4+/+ and Tmod4−/− muscles.
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complex; instead, Tmod4/Lmod3 versus Tmod1/Lmod2 co-
expression might be mediated by a gene regulatory network, like
other combinations of muscle cytoskeletal protein isoforms (Olson
and Nordheim, 2010; Schiaffino and Reggiani, 1996).
Depletion of Tmod1 from wild-type or Tmod4-deficient
muscles results in increased thin filament lengths
A direct role for sarcomeric Tmods in regulating thin filament
length in mammalian skeletal muscle has remained elusive, owing
to developmental compensation by other Tmod isoforms in
Tmod1−/− and Tmod4−/− muscles (Fig. 3; Gokhin and Fowler,
2011a; Gokhin et al., 2010). To overcome this, we depleted Tmod1
from adult muscles using in vivo RNAi, in which we injected
Tmod4+/+ and Tmod4−/− TA muscles with either negative-control
siRNA (siScr) or one of two Tmod1-targeting siRNAs (siTmod1a
and siTmod1b). Muscle fibers from siScr-injected TA muscles
consistently exhibited striated Tmod1 staining, whereas fibers from
siTmod1a- and siTmod1b-injected muscles showed widespread
loss of striated Tmod1 staining in many fibers (Fig. 5A,B; Fig. S4).
The extent of knockdown was quantified as the percentage of fibers
with striated Tmod1 staining, which was ∼100% for siScr-injected
TA muscles but reduced to ∼25-50% for siTmod1a- and
siTmod1b-injected muscles (Fig. 5C). The effects of siTmod1a
and siTmod1b injection were similar in Tmod4+/+ and Tmod4−/−
muscles (Fig. 5A-C), despite substantially higher Tmod1 mRNA
levels and Tmod1 protein levels in Tmod4−/− muscles prior to
Fig. 4. Deletion of Tmod4 induces downregulation of Lmod3 with concomitant upregulation of Lmod2, but does not impact the localization of nebulin.
(A-C) Longitudinal cryosections of TA muscles from 2-month-old Tmod4+/+ and Tmod4−/− mice were immunostained for neb-N (A), neb-C (B) or Lmod3 (C),
immunostained for α-actinin, and phalloidin-stained for F-actin. P, thin filament pointed ends; Z, Z-line. Scale bars: 1 µm. (D) Distances of neb-N and Lmod3 from
the Z-line in TA and soleusmuscles from 2-month-old Tmod4+/+ and Tmod4−/−mice determined using DDecon analysis of fluorescence images. Error bars reflect
mean±s.d. of n=50 myofibrils/genotype randomly selected from n=4 muscles/genotype. (E) Western blots of homogenates of TA muscles from 2-month-old
Tmod4+/+ and Tmod4−/−micewere probed using antibodies against Lmod3 and Lmod2. Gapdh was used as a loading control. (F) Quantification of western blots.
Error bars reflect mean±s.e.m. of n=4 lanes/genotypewithin a single blot. *P<0.05. (G) Expression of Lmod3 and Lmod2mRNA in TAmuscles from Tmod4+/+ and
Tmod4−/− mice determined by qRT-PCR. Error bars reflect mean±s.e.m. of n=3 replicates. *P<0.05.
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injection (Fig. 3). Tmod3 remained localized to Z-line-flanking and
M-line puncta in siTmod1a- and siTmod1b-injected muscles (Fig.
S5A,B), indicating that siRNA knockdown of Tmod1 does not
induce compensatory translocation of Tmod3 from the SR to the
thin filament pointed ends, as observed in Tmod1−/− muscle
(Gokhin and Fowler, 2011a; Gokhin et al., 2010).
Tmod1-negative fibers in siTmod1a- and siTmod1b-injected TA
muscles exhibited a wider breadth of sarcomeric F-actin staining,
indicative of increased thin filament lengths (Fig. 5A,B, yellow
brackets). Indeed, thin filament lengths in Tmod1-positive fibers
were ∼0.98 µm, whereas thin filament lengths in Tmod1-negative
knockdown fibers increased to ∼1.13 µm (Fig. 5D). This ∼15%
increase is slightly greater than the ∼10% increase observed in
dystrophic TA muscles exhibiting m-calpain-mediated proteolysis
of Tmod1 (Gokhin et al., 2014b), suggesting that residual
unproteolyzed Tmod1 remaining in dystrophic TA muscle might
still confer partial length-regulating activity. Neb-N remained
normally localized at ∼0.95 μm from the Z-line in siTmod1a- and
siTmod1b-injected muscles (Fig. S5C-E), indicating that overall
thin filament elongation was driven specifically by elongation of the
nebulin-free distal segment and not the nebulin-coated proximal
segment (Gokhin and Fowler, 2013). Depletion of Tmod1 from
Tmod4+/+ fibers did not affect variability of thin filament lengths
(Fig. 5D; data not shown), even though the abundance of Tmod1
indicates that it caps just a subset (∼10%) of thin filaments
(Table 1). Notably, Tmod4 remained normally localized at the
Fig. 5. RNAi knockdown of Tmod1
from Tmod4+/+ or Tmod4−/−
muscles leads to increased thin
filament lengths. (A,B) TA muscles
from 2-month-old Tmod4+/+ (A) and
Tmod4−/− (B) micewere injected with
siScr, siTmod1a or siTmod1b and
excised 1 week post-injection.
Shown are longitudinal cryosections
immunostained for Tmod1 and
α-actinin, and phalloidin-stained for
F-actin. For siTmod1a, images of a
muscle fiber away from the siRNA
injection site (‘Tmod1-positive cell’)
are also shown, serving as an
internal control. Yellow brackets
signify thin filament arrays (I-Z-I
regions) that widen after Tmod1
knockdown. P, thin filament pointed
ends; Z, Z-line. Scale bars: 1 µm.
(C) Extent of Tmod1 knockdown as
measured by the percentage of fibers
with striated Tmod1 immunostaining
in TA muscles injected with siScr,
siTmod1a or siTmod1b. Error bars
reflect mean±s.e.m. of n=3-4
muscles. (D,E) Measurement of thin
filament lengths (D) and sarcomere
lengths (E) in TA muscles at maximal
plantarflexion in 2-month-old
Tmod4+/+ and Tmod4−/− mice
injected with siScr, siTmod1a or
siTmod1b, determined using
DDecon analysis of fluorescence
images. Error bars reflect mean±s.d.
of n=50 myofibrils/genotype















pointed ends of the elongated thin filaments in siTmod1a- and
siTmod1b-injected Tmod4+/+ muscles (Fig. 6A,C), indicating that
Tmod4 acts as a dynamic cap, similar to Tmod1 (Gregorio et al.,
1995; Littlefield et al., 2001). Moreover, Lmod3 remained
∼0.95 µm from the Z-line in siTmod1a- and siTmod1b-injected
Tmod4+/+muscles (Fig. 6B,C), coincident with Neb-N (Fig. S5C-E),
indicating that Lmod3 does not translocate to the pointed end to
promote thin filament elongation in the absence of Tmod1.
Increased thin filament lengths in Tmod1-negative fibers were
associated with increased sarcomere lengths at an ankle joint angle
corresponding to maximal plantar flexion (Fig. 5E), suggesting
that thin filament elongation drives sarcomere growth by inducing
longitudinal separation of successive Z-lines. Coordination of thin
filament length with sarcomere length has been observed during
growth of Drosophila indirect flight muscle (Mardahl-Dumesnil
and Fowler, 2001) but the relevance of this to mammalian muscle is
unclear (Littlefield and Fowler, 2008). It remains unknown whether
thin filament elongation might drive sarcomere length changes
during mammalian muscle development, and whether thin filament
length changes might underlie sarcomere length changes under
conditions of muscle adaptation and remodeling (Lieber, 2002).
DISCUSSION
Here, we show that Tmod4 is the predominant sarcomeric Tmod at
both the transcript and protein level in both fast and slow skeletal
muscles, but Tmod4:Tmod1 ratios are muscle specific. Muscle-
specific sarcomeric Tmod isoform distributions represent a novel,
myofibril-intrinsic signature of muscle types, similar to MHC,
α/βTM and troponin isoform distributions and Z-line widths (Pette
and Staron, 1990). Although Tmod4 is the predominant Tmod in all
muscles examined, deletion of Tmod4 does not produce an overt
myopathy, as normal myofibril organization, thin filament lengths,
and actomyosin contractile function are observed in Tmod4−/−
skeletal muscle. This is probably due to the compensatory
upregulation of Tmod1 being of sufficient magnitude to
repopulate nearly all the thin filament pointed ends available upon
Tmod4 deletion, which occurs during embryonic skeletal muscle
development and does not require postnatal muscle use. Such a
compensation mechanism appears to be a mammalian innovation,
as Tmod4 deficiency leads to severe myofibril disruption and
nemaline myopathy-like phenotypes in zebrafish and Xenopus
(Berger et al., 2014; Nworu et al., 2015). The dispensability of
Tmod4 for mammalian skeletal muscle development and
organization also agrees with the fact that no human TMOD4-
based nemaline myopathies have been identified to date, despite the
fact that numerous nemaline myopathy-causing mutations in other
thin filament structural components and actin-associated proteins
have been identified (Romero et al., 2013).
Tmod regulation of thin filament lengths
Our finding that RNAi depletion of Tmod1 leads to thin filament
elongation in both wild-type and Tmod4-deficient TAmuscle fibers
Fig. 6. RNAi knockdown of Tmod1 fromwild-typemuscle does not alter the localization of Tmod4 or Lmod3. (A,B) TAmuscles from 2-month-old Tmod4+/+
mice were injected with siScr, siTmod1a or siTmod1b and excised 1 week post-injection. Shown are longitudinal cryosections immunostained for Tmod1 and
either Tmod4 (A) or Lmod3 (B), and phalloidin-stained for F-actin. Yellow brackets signify thin filament arrays (I-Z-I regions) that widen after Tmod1 knockdown. P,
thin filament pointed ends; Z, Z-line. Scale bars: 1 µm. (C) Distances of Tmod4 and Lmod3 from the Z-line in TAmuscles from 2-month-old Tmod4+/+mice injected
with siScr, siTmod1a or siTmod1b, determined using DDecon analysis of fluorescence images. Error bars reflect mean±s.d. of n=50 myofibrils/genotype
randomly selected from n=3-4 muscles/genotype. *P<0.01 versus siScr.
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provides the first direct demonstration that pointed-end capping by a
sarcomeric Tmod isoform is inversely related to thin filament length
in mammalian skeletal muscle fibers. Although it has been known
for some time that pointed-end capping by sarcomeric Tmods is
inversely related to thin filament length in cardiac myocytes as
well as Drosophila indirect flight muscle (Bliss et al., 2014;
Gregorio et al., 1995; Littlefield et al., 2001;Mardahl-Dumesnil and
Fowler, 2001; Sussman et al., 1998), the only evidence for Tmod
participation in thin filament length regulation in skeletal muscle
has been indirect evidence obtained from dystrophic mouse
muscles, in which m-calpain-induced proteolysis of Tmod1 is
associated with thin filament elongation (Gokhin et al., 2014b).
However, the utility of dystrophic muscles for studying Tmod-
mediated thin filament length regulation is constrained by the fact
that residual unproteolyzed Tmod remains in muscle after Ca2+
influx and m-calpain induction, and that the extent of m-calpain
proteolysis is highly variable and depends on both the muscle type
and the severity of the dystrophy (Gokhin et al., 2014b). Moreover,
thin filament elongation in dystrophic muscle could be due to
m-calpain proteolysis of non-Tmod components (Tidball and
Spencer, 2000). The RNAi approach utilized here overcomes
these limitations and illuminates a direct link between Tmod1-
mediated capping and length regulation in both normal (wild type)
and developmentally compensated (Tmod4 deficient) contexts.
In wild-type muscles, only ∼10% of filaments are capped by
Tmod1 (with the remainder capped by Tmod4). Upon siRNA
depletion of Tmod1 from wild-type muscles, Tmod4 now caps the
pointed ends of all of the now-longer thin filaments. This is
consistent with dynamic capping by Tmod4, as previously observed
for Tmod1 in chick cardiac myocytes and quail skeletal myotubes
(Gregorio et al., 1995; Littlefield et al., 2001; Pappas et al., 2010). In
cardiac myocytes, thin filament lengths are thought to arise from
competition between Tmod1 and actin subunits at pointed ends,
and, thus, reduced total Tmod would be expected to allow more
frequent actin subunit addition, leading to thin filament elongation
(Gregorio et al., 1995; Littlefield et al., 2001). Thin filament
elongation is unlikely to be due to lower affinity of Tmod4 for thin
filament pointed ends compared with Tmod1, as no differences have
been observed between Tmod1 and Tmod4 with respect to their
actin-capping and tropomyosin-actin-capping activities (Almenar-
Queralt et al., 1999). Notably, length uniformity is maintained after
thin filament elongation, indicative of a constitutive mechanism for
equalization of thin filament lengths across the sarcomere; such a
constitutive mechanism for organelle size control has been proposed
for Chlamydomonas flagella (Ludington et al., 2012).
Despite the compensatory upregulation of Tmod1 and normal
thin filament lengths in Tmod4-deficient muscles, Tmod4-deficient
muscles provide novel insights into mechanisms of Tmod-mediated
regulation of actin pointed end dynamics and thin filament lengths.
Unlike wild-type muscles, in which only ∼10% of filaments are
capped by Tmod1, Tmod4-deficient muscles have almost all of their
thin filaments capped by Tmod1. Surprisingly, regardless of these
markedly different proportions of Tmod1 in wild-type and Tmod4-
deficient muscles, RNAi depletion of the small amount of Tmod1 in
wild-type muscle, where 90% of total Tmod remains at pointed
ends, has an identical effect as depletion of Tmod1 from Tmod4-
deficient muscle, where no Tmod remains at pointed ends (i.e. thin
filament lengthening by ∼15% in both cases). We suggest two
possibilities to explain this apparent paradox. (1) Thin filament
lengths might be inversely related to sarcomeric Tmod1+4 levels,
but this relationship might not be stoichiometric. Rather, any
depletion of sarcomeric Tmod1+4 levels leading to uncapped
pointed ends might reduce total Tmod levels below a threshold
required to inhibit actin subunit association and filament
lengthening. (2) Alternatively, Tmod1-deficient sarcomeres from
Tmod4-deficient muscles might actually have a greater propensity
for thin filament elongation owing to further reductions in total
Tmod and increased actin subunit association kinetics compared
with Tmod1-deficient sarcomeres from wild-type muscles;
however, in this latter case, excessive elongation of uncapped thin
filaments might be blocked by a structural constraint or ‘ceiling’ on
thin filament elongation. Myosin thick filaments, titin and/or M-line
components might contribute to such a ceiling, as suggested
previously (Littlefield and Fowler, 1998).
Relationship between Tmods and Lmods in striatedmuscles
Deletion of Tmod4 with compensatory upregulation of Tmod1
during development leads to an unexpected Lmod isoform switch,
with downregulation of Lmod3 and upregulation of Lmod2,
suggesting the existence of a gene regulatory network mediating
preferential Tmod4-Lmod3 and Tmod1-Lmod2 co-expression.
Preferential Tmod4-Lmod3 and Tmod1-Lmod2 co-expression is
also supported by previous findings: (1) Lmod3 is the predominant
Lmod isoform in skeletal muscle, in which skeletal myofibrils
contain predominantly Tmod4 on thin filament pointed ends (this
study; Cenik et al., 2015); (2) Lmod2 is the predominant Lmod
isoform in cardiac muscle, in which cardiac myofibrils contain
solely Tmod1 on thin filament pointed ends (Chereau et al., 2008;
Conley et al., 2001; Gokhin and Fowler, 2011b; Skwarek-
Maruszewska et al., 2010); (3) LMOD3-deficient nemaline
myopathy patients exhibit dramatic loss of TMOD4 protein (Yuen
et al., 2014). Although the genetic circuitry regulating preferential
Tmod4-Lmod3 and Tmod1-Lmod2 co-expression remains
unknown, a possible candidate is the myocardin-related
transcription factor (MRTF)/Srf pathway, which has been
proposed to activate muscle-specific genes via a feedback loop
initiated by Lmod3-mediated actin polymerization and depletion
of soluble actin (Cenik et al., 2015). It is conceivable that co-
expression of Tmod4-Lmod3 versus Tmod1-Lmod2 leads to
different soluble actin levels, leading to different extents of
MRTF activation and Srf and Mef2 activity, and expression of
skeletal versus cardiac combinations of cytoskeletal genes.
Our unexpected observation that Lmod3 localizes ∼0.95 µm
away from the Z-line in mouse skeletal muscle indicates that Lmod3
is coincident with neb-N at the junction between the nebulin-coated
proximal segment and nebulin-free distal segment of the thin
filament (Gokhin and Fowler, 2013). This Lmod3 localization is
also similar to LMOD3 localization in some human muscle
biopsies, although human LMOD3 localization is more
heterogeneous and subject specific, with variable LMOD3
staining observed along the length of the filament itself, and, in a
subset of instances, coinciding with both neb-N and TMOD (Yuen
et al., 2014). Our co-immunoprecipitation experiments argue
against the existence of Tmod-Lmod complexes, although we
cannot rule out the possibility that Tmod-Lmod interactions are
weak, transient and/or dependent on additional regulatory factors.
Regardless, both observed Lmod3 localization patterns imply that
Lmods exert at least some of their actin-regulatory effects on thin
filaments by binding along filament sides. The identical positioning
of Lmod3 and neb-N ∼0.95 µm away from the Z-line also agrees
with the fact that both Lmod3 and neb-N are substrates of the
ubiquitylation inhibitor Klhl40 (Garg et al., 2014). Lmod3/neb-N/
Klhl40 interactions might constitute a novel actin-remodeling
complex along the side of the thin filament, at the junction
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between the nebulin-coated proximal segment and nebulin-free
distal segment of the thin filament.
MATERIALS AND METHODS
Generation and genotyping of Tmod4−/− mice
Mouse embryonic stem cells with a lacZ/neo insertion in intron 2 of the
Tmod4 gene were obtained from the Knockout Mouse Project repository
(project ID 33375) at the University of California-Davis and stored in liquid
N2 until use. Blastocyst injection and implantation into pseudopregnant
females were performed at theMurine Genetics Core at The Scripps Research
Institute. Resulting male chimeras were bred to C57BL/6J females to obtain
germline transmission. Intercrosses of Tmod4+/− mice were performed to
generate Tmod4−/− mice and control Tmod4+/+ littermates. The presence of
wild-type and mutant Tmod4 alleles was confirmed by automated qPCR
genotyping of tail-snip biopsies (Transnetyx, Cordova, TN, USA). Adult
mice were sacrificed by isoflurane inhalation followed by cervical
dislocation, and newborn (P0) mice were sacrificed by isoflurane inhalation
followed by decapitation. All experiments were performed according to NIH
animal care guidelines, as approved and enforced by the Institutional Animal
Care and Use Committee at The Scripps Research Institute.
Antibodies
Primary antibodies were as follows: rabbit polyclonal antiserum to chicken
Tmod4 preadsorbed by passage through a Tmod1 Sepharose column
(R3577; 1:25 for cryosections, 1:2500 forwestern blots; Gokhin et al., 2010),
affinity-purified rabbit polyclonal anti-human TMOD1 (R1749; 3.1 µg/ml
for cryosections;Gokhin et al., 2010), rabbit polyclonal antiserum to residues
340-359 of a human TMOD1 peptide (PA2211; 1:5000 for western blots;
Gokhin et al., 2012), rabbit polyclonal antiserum to human TMOD3
preadsorbed by passage through a Tmod1 Sepharose column (R5168; 1:100
for cryosections, 1:1000 for western blots; Gokhin et al., 2010), affinity-
purified rabbit polyclonal anti-nebulinM1M2M3 domain (NEB-1; 1:100 for
cryosections; Myomedix, Mannheim, Germany), affinity-purified rabbit
polyclonal anti-nebulin M160-164 domain (10 µg/ml for cryosections; a gift
from Carol C. Gregorio, University of Arizona, Tucson, AZ, USA), rabbit
polyclonal anti-Lmod3 (14948-1-AP; 1:100 for cryosections, 1:1000 for
western blots; Proteintech, Chicago, IL, USA), rabbit polyclonal anti-Lmod2
(S-12; 1:200 forwestern blots; SantaCruzBiotechnology,Dallas, TX,USA),
mouse monoclonal anti-Tmod1 (mAb9; 1:100 for cryosections; Gregorio
et al., 1995), mouse monoclonal anti-α-actinin (EA53; 1:100 for
cryosections; Sigma-Aldrich), mouse monoclonal anti-actin (C4; 1:10,000
for western blots; EMD Millipore) and mouse monoclonal anti-GAPDH
(1D4; 1:5000 for western blots; Novus Biologicals). Secondary antibodies
were as follows: Alexa Fluor 488-conjugated goat anti-rabbit IgG (1:200 for
cryosections; Life Technologies), Alexa Fluor 647-conjugated goat anti-
mouse IgG (1:200 for cryosections; Life Technologies), 800CW-conjugated
goat anti-rabbit IgG (1:20,000 for western blots; LI-COR Biosciences) and
680LT-conjugated goat anti-mouse IgG (1:20,000 forwestern blots; LI-COR
Biosciences).
Immunostaining and confocal microscopy
TA and soleus muscles were relaxed, fixed, cryosectioned and
immunostained as described previously (Gokhin et al., 2014b). Alexa
488- or Alexa 647-conjugated secondary antibodies were supplemented
with rhodamine-phalloidin (1:100; Life Technologies) to stain F-actin.
Images of single optical sections were collected at room temperature on
either a Bio-Rad Radiance 2100 laser-scanning confocal microscope
mounted on a Nikon TE2000-U microscope, or on a Zeiss LSM780 laser-
scanning confocal microscope mounted on a Zeiss Axio Observer.Z1
microscope. Images were acquired using 100× (1.4 NA) Plan-Apochromat
oil-objective lenses with digital zoom of up to 3×. Images were processed
with Volocity 6.3 (PerkinElmer), and image figures were constructed in
Adobe Illustrator CS5.1.
Thin filament length measurements
DDecon was used to measure distances of sarcomeric Tmods, neb-N and
Lmod3 from the Z-line as well as the breadth of the F-actin (phalloidin)
signal across the Z-lines of adjacent half-sarcomeres (I-Z-I arrays) using
line-scans of fluorescence images, as described previously (Gokhin et al.,
2012; Littlefield and Fowler, 2002). Tmod distances were determined from
Tmod1 and Tmod4 localization in Tmod4+/+ muscles or just Tmod1
localization in Tmod4−/− muscles. DDecon was performed using an open-
source ImageJ plugin (available at http://www.scripps.edu/fowler/ddecon/).
Distances were calculated by converting pixel sizes into μm.
Histology
Transverse sections of TA, EDL and soleus muscles were subjected to
Haematoxylin and Eosin (H&E) and Gömöri trichrome staining. Images
were collected on a Zeiss Axioskop bright-field microscope using a 10×
(0.45 NA) air-objective lens (zoom=2) and a Zeiss Axiocam CCD camera at
RT. Centrally nucleated fibers were manually counted in H&E-stained
images. Fiber cross-sectional area was determined by manual segmentation
of fibers and converting enclosed pixel areas into μm2.
Transmission electron microscopy
Mice were perfusion fixed in 4% paraformaldehyde +1.5% glutaraldehyde
in 0.1 M cacodylate buffer, and TA and EDL muscles were processed for
transmission electron microscopy as described previously (Gokhin et al.,
2010). Sections (60 nm thin) were cut, mounted on copper slot grids coated
with parlodion, stained with uranyl acetate and lead citrate, and examined on
a Philips CM100 transmission electron microscope at 80 kV.
Co-immunoprecipitation
Co-immunoprecipitation was performed as described previously (Gokhin
and Fowler, 2011a). Briefly, mouse TA and EDL muscles were
homogenized in RIPA buffer supplemented with protease inhibitor
cocktail (1:1000) and centrifuged at 10,000 g. The resulting supernatant
was divided into 1-ml aliquots, to which one of the following was added:
2 μg rabbit polyclonal anti-Tmod4 (R3577), 2 μg rabbit polyclonal anti-
human Tmod1 (R1749) or 2 μg of preimmune control IgG. Antibody-bound
complexes were adsorbed to 100 μl μMACS Protein A-conjugated super-
paramagnetic MicroBeads (Miltenyi Biotec) and incubated for 1 h on ice,
followed by passage through a μColumn (Miltenyi Biotec) using a μMACS
magnetic separator (Miltenyi Biotec). Beads were washed with RIPA buffer
and eluted with 100 μl of 1× SDS sample buffer. The input extract (diluted
in 2× SDS sample buffer) and eluted immunoprecipitates were then
subjected to SDS-PAGE and western blotting, as described below.
Gel sample preparation and western blotting
For western blots of whole-muscle homogenates, TA, EDL, soleus,
diaphragm, and neonatal leg and flank muscles were dissected in ice-cold
PBS and homogenized with a Tekmar Tissumizer in ten volumes of PBS
supplemented with protease inhibitor cocktail (1:1000). Protein standards for
quantitative western blotting were prepared as described previously (Gokhin
et al., 2014b). First, protein standards for SDS-PAGE and Coomassie Blue
staining to determine actin concentrations in isolated myofibrils were
prepared from rabbit skeletal muscle actin (Cytoskeleton, Denver, CO, USA).
Second, protein standards for quantitative western blots were prepared by
spiking increasing volumes of Tmod1−/− (Gokhin et al., 2010) or Tmod4−/−
TA muscle homogenates with increasing amounts of recombinant purified
human Tmod1 or mouse Tmod4 proteins (Yamashiro et al., 2010),
respectively. This approach equalized the effects of endogenous non-Tmod
proteins on the differential western transfer efficiencies of endogenous versus
recombinant purified Tmods, as described previously (Gokhin et al., 2014b).
All protein preparations were solubilized in equal volumes of 2× SDS
sample buffer and boiled for 5 min. SDS-PAGE, transfer to nitrocellulose,
blocking, and antibody incubations were performed as described previously
(Gokhin et al., 2014b). Bands were visualized using a LI-COR Odyssey
infrared imaging system, and background-corrected band intensities were
densitometrically quantified in ImageJ. Where appropriate, band intensities
were normalized to Gapdh to control for loading.
MHC isoform composition
Gel samples of whole-muscle homogenates were prepared as described for
western blotting. Proteins were then separated by SDS-PAGE on 8% Tris-
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glycine mini-gels, as described previously (Talmadge and Roy, 1993). SDS-
PAGE was performed for 16 h at 140 V. The upper tank buffer was
supplemented with 1 mM dithiothreitol, and the lower tank buffer was one-
sixth the concentration of the upper tank buffer (Kohn andMyburgh, 2006).
Gels were silver-stained, and background-corrected intensities of type-1,
-2A, -2X and -2B MHC bands were densitometrically quantified in ImageJ.
Skinned muscle fiber mechanics
Physiological measurement of specific force production, rate constant of
force redevelopment after unloaded sarcomere shortening (ktr), thin filament
Ca2+ sensitivity (pCa50), and cooperativity of thin filament activation [Hill
coefficient (nH)] using skinned, Ca
2+-activated TA muscle fibers was
performed as described previously (Ochala et al., 2014).
RNA sequencing
RNA sequencing was performed as described previously (Christodoulou
et al., 2011). Briefly, an RNA sequencing library was constructed by random
hexamer priming of mRNA pooled from three biological replicates of wild-
type mouse TA, soleus, diaphragm and left ventricular muscles
(Domenighetti et al., 2014). The resulting cDNA library was uniformly
amplified to subsaturating levels. Alignment of reads was performed using
TopHat 1.0.14 (Trapnell et al., 2009). Read-depth profiles were constructed
using TopHat’s ‘wiggles’ tool, and values were normalized to total aligned
reads and uploaded onto the University of California-Santa Cruz Genome
Browser (http://genome.ucsc.edu). RNA sequencing data have been
deposited in Gene Expression Omnibus under accession number GSE75318.
qRT-PCR
Total RNA was extracted from skeletal muscle tissues with TRIzol reagent
(Life Technologies) and reverse-transcribed into cDNA using SuperScript
III Reverse Transcriptase with random hexamer primers (Life
Technologies), according to the manufacturer’s instructions. cDNA was
analyzed using a Bio-Rad iCycler iQ apparatus, with each reaction
containing 60 ng cDNA as template, LightCycler 480 SYBR Green I
Master (Roche), and the following gene-specific primers (Integrated DNA
Technologies): Tmod4 forward, 5′-GATGCGGTAGAGATGGAGATG-3′;
Tmod4 reverse, 5′-TCTCTTCTTTTGCTGACGACG-3′; Tmod1 forward,
5′-CAACGCCATGATGAGCAAC-3′; Tmod1 reverse, 5′-CATCGGTAG-
AACACGTCCAG-3′; Lmod3 forward, 5′-CCGCTGGTGGAAATCACT-
CCC-3′; Lmod3 reverse, 5′-ACTCCAGCTCCTTTGGCAGTTGC-3′;
Lmod2 forward, 5′-TTGGAGAAGGAACGGCTGGG-3′; Lmod2 reverse,
5′-CCTCAGAGACTTCGCTGTTGCTCTC-3′; Gapdh forward, 5′-ACC-
ACAGTCCATGCCATCAC-3′; Gapdh reverse, 5′-TCCACCACCCTGT-
TGCTGTA-3′. Tmod4 and Tmod1 primers (Gokhin et al., 2014b) and
Lmod3 and Lmod2 primers (Cenik et al., 2015) were as previously
published, and Gapdh primers were ReadyMade primers from Integrated
DNA Technologies. Relative gene expression levels were calculated as
2−ΔΔCt with normalization to Gapdh, as described previously (Livak and
Schmittgen, 2001).
In vivo RNAi
Mice were anesthetized with isoflurane (4% for induction, 2% for
maintenance) with 1 liter/min O2, until cessation of the toe-pinch
withdrawal reflex was attained. One nmol siRNA and Lipofectamine
RNAiMAX transfection reagent (1:100, Life Technologies) were diluted
to a final volume of 10 µl, drawn into a 25-gauge syringe needle, and
slowly injected into the midbelly of the TA muscle. Two different Silencer
Select siRNA constructs (Life Technologies) were used to knock down
Tmod1: siTmod1a forward, 5′-CUAGAAGAGGUUAAUCUUATT-3′;
siTmod1a reverse, 5′-UAAGAUUAACCUCUUCUAGTT-3′; siTmod1b
forward, 5′-GCUGAAAUGCUGAAAGUGATT-3′; siTmod1b reverse, 5′-
UCACUUUCAGCAUUUCAGCAA-3′. As a negative control, a Stealth
RNAi negative control duplex (Life Technologies) was used and is referred
to as siScr. After injection, the ankle joint was passively dorsi- and
plantarflexed to facilitate distribution of injectate throughout the TA, and
mice were removed from anesthesia and allowed to recover on a heated pad.
After 1 week, TA muscles were excised and processed for immunostaining
and confocal microscopy, as described above.
Statistics
Data are presented as either mean±s.d. or mean±s.e.m., where appropriate.
Differences between groups were detected using Student’s t-test or one-way
ANOVA with post hoc Fisher’s LSD tests, where appropriate. Statistical
significance was defined as P<0.05. Analysis was performed in Microsoft
Excel.
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